Disposition of the flavonoid quercetin in rats after single intravenous and oral doses

被引:107
作者
Khaled, KA
El-Sayed, YM
Al-Hadiya, BM
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia
关键词
quercetin; pharmacokinetics; oral bioavailability; tissue distribution; mean time parameters;
D O I
10.1081/DDC-120018375
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The pharmacokinetic and mean time tissue distribution parameters, after a single 50-mg/kg dose of quercetin administered as intravenous bolus, oral solution, and oral suspension, were determined using rat as an animal model. Following intravenous administration, the elimination rate constant and the elimination half-life were found to be 0.0062 min(-1) and 111 min, respectively. Examining the mean time tissue distribution parameters reflected a strong binding affinity of the drug molecules to both plasma and tissue proteins. In addition, the low permeability rate of drug molecules in the peripheral system was demonstrated. Following the oral administration of the drug, the extent of absorption was greater from solution than from suspension. Moreover, the solution showed a shorter T-max and a higher C-max than suspension. The absolute bioavailability for the: solution was 0.275 and that for suspension was, 0.162. The mean residence time (MRT) and the mean absorption time (MAT) were higher for suspension, reflecting the need for dissolving the drug in order to be absorbed. The mean (in-vivo) dissolution time (MDTin-vivo) was 34.5 min. Thus, an oral quercetin formulation that can readily form a drug solution in the gastrointestinal tract may enhance the absorption of the drug.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 30 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]  
BORS W, 1990, METHOD ENZYMOL, V186, P343
[3]  
CLEGG K. M., 1968, Journal of Food Technology, V3, P277
[5]   QUINIDINE PHARMACOKINETICS IN MAN - CHOICE OF A DISPOSITION MODEL AND ABSOLUTE BIOAVAILABILITY STUDIES [J].
GUENTERT, TW ;
HOLFORD, NHG ;
COATES, PE ;
UPTON, RA ;
RIEGELMAN, S .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (04) :315-330
[6]  
GUGLER R, 1973, CLIN CHEM, V19, P36
[7]   DISPOSITION OF QUERCETIN IN MAN AFTER SINGLE ORAL AND INTRAVENOUS DOSES [J].
GUGLER, R ;
LESCHIK, M ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :229-234
[8]   CONTENT OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS OF 28 VEGETABLES AND 9 FRUITS COMMONLY CONSUMED IN THE NETHERLANDS [J].
HERTOG, MGL ;
HOLLMAN, PCH ;
KATAN, MB .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1992, 40 (12) :2379-2383
[9]   CONTENT OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS OF TEA INFUSIONS, WINES, AND FRUIT JUICES [J].
HERTOG, MGL ;
HOLLMAN, PCH ;
VANDEPUTTE, B .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1993, 41 (08) :1242-1246
[10]   ENHANCEMENT OF THE ANTIPROLIFERATIVE ACTIVITY OF CIS-DIAMMINEDICHLOROPLATINUM(II) BY QUERCETIN [J].
HOFMANN, J ;
FIEBIG, HH ;
WINTERHALTER, BR ;
BERGER, DP ;
GRUNICKE, H .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :536-539